Zhaohu Xie

Zhaohu Xie


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JZJian Zhang
Jian Zhang
BCBingbing Chen
Bingbing Chen
QYQianqian Yang
Qianqian Yang
HYHeguo Yan
Heguo Yan
NXNiqin Xiao
Niqin Xiao
ZLZhaofu Li
Zhaofu Li
Osteoporosis (OP) and osteoarthritis (OA) are two common degenerative musculoskeletal disorders associated with aging and are traditionally classified and managed as distinct disease entities. Emerging evidence suggests that OP and OA may share bidirectional associations and common biological mechanisms, and that under specific pathological conditions they may develop into a mutually reinforcing comorbid state. The comorbidity of osteoporosis and osteoarthritis (OP–OA) is not a simple superimposition of bone loss and cartilage degeneration; rather, it represents a disorder of the osteochondral unit centered on disruption of the subchondral bone microenvironment. Alterations in the structural strength, remodeling dynamics, vascular and neural status, and bone marrow lesions of subchondral bone collectively reshape the local microenvironment, thereby directly affecting mechanical signal transmission and cellular behavior within the joint. Focusing on the subchondral bone microenvironment as the central pathological nexus, this review systematically summarizes how mechanical imbalance, aberrant bone remodeling, inflammatory activation, metabolic dysregulation, and cellular senescence jointly remodel the local niche in OP–OA comorbidity. These microenvironmental changes further induce phenotypic remodeling and fate deviation of bone marrow mesenchymal stem cells, bone remodeling-related cells, osteoimmune cells, and chondrocytes. On this basis, we integrate the regulatory roles of developmental signaling, mechanotransduction pathways, and inflammatory–immune signaling networks, and propose that microenvironment-driven cell fate plasticity may serve as a key mechanistic hub promoting the initiation and progression of OP–OA comorbidity as well as the persistent destabilization of the osteochondral unit. This perspective may help overcome the limitations of current studies that address OP and OA separately, and may provide a theoretical framework for early identification and stratification, biomarker discovery, and combined precision-targeted interventions for this comorbid condition.

26 September 2026 in Cells
Verified
Journal Article
Open access
PDF file
JZJian Zhang
Jian Zhang
BCBingbing Chen
Bingbing Chen
YXYundong Xu
Yundong Xu
HYHeguo Yan
Heguo Yan
NXNiqin Xiao
Niqin Xiao
ZLZhaofu Li
Zhaofu Li
Osteoarthritis (OA) is now widely discussed as a whole-joint immunometabolic disease involving cartilage, synovium, and subchondral bone, rather than as cartilage degeneration driven only by mechanical stress. Tissue injury, cell death, mitochondrial dysfunction, and extracellular matrix degradation can lead to the persistent release of damage-associated molecular patterns (DAMPs), which activate innate immune responses through pattern recognition receptors (PRRs). A key unresolved issue is why inflammation can persist or recur when there is no continuous external stimulus. Trained immunity provides an emerging framework for approaching this problem, with initial direct evidence now available in circulating monocytes from knee OA but broader validation still lacking. Following an initial stimulus and a subsequent resting interval, monocytes and macrophages may retain epigenetic and metabolic alterations that modify their responses to later homologous or heterologous challenges. This review summarizes the sources of DAMPs and their recognition mechanisms in the OA microenvironment, with particular attention to their potential links with trained immunity in monocyte–macrophage populations. We discuss PRR-mediated changes in chromatin accessibility, histone modifications, DNA methylation, and non-coding RNA regulation, as well as immunometabolic events such as enhanced glycolysis, tricarboxylic acid cycle remodeling, mitochondrial dysfunction, and accumulation of key metabolites. We also examine how monocyte–macrophage populations with persistent hyperresponsiveness after stimulus withdrawal and restimulation may contribute to persistent synovitis, cartilage matrix degradation, and abnormal subchondral bone remodeling. Finally, we summarize therapeutic opportunities potentially relevant to the proposed links between DAMP signaling and trained immunity. Recent evidence that high-mobility group box 1 (HMGB1) primes a trained phenotype in circulating monocytes provides initial direct support for DAMP-associated trained immunity in knee OA. However, its generalizability across independent cohorts, other DAMP classes, myeloid-cell compartments, disease stages, and OA phenotypes remains to be established.

Verified
Journal Article
Open access
PDF file
QHQiumei He
Qiumei He
XGXiaoqiao Gu
Xiaoqiao Gu
QYQianqian Yang
Qianqian Yang
NXNiqin Xiao
Niqin Xiao
XLXi Liu
Xi Liu
ZLZhaofu Li
Zhaofu Li
Sjögren’s syndrome is a chronic systemic autoimmune disease with primary (pSS) and secondary forms. Epidemiological evidence suggests a higher prevalence of depressive symptoms and depression in pSS than in the general population, indicating possible disease-specific susceptibility. The underlying mechanisms remain unclear, limiting early identification and targeted intervention. This narrative review examines five domains of depression susceptibility in pSS: inflammatory pathways, neuroendocrine regulation, the gut–brain axis, medication effects, and psychosocial factors. Interleukin-6, tumor necrosis factor-α, and interferon-α may contribute by activating the indoleamine 2,3-dioxygenase–kynurenine pathway, downregulating brain-derived neurotrophic factor, and inhibiting hippocampal neurogenesis. Hypothalamic–pituitary–adrenal axis dysfunction may provide a neuroendocrine link, whereas gut microbial imbalance may affect emotional regulation through immune and neural signaling. Glucocorticoids, hydroxychloroquine, and calcineurin inhibitors may increase neuropsychiatric risk through multiple pathways. Somatic symptoms and social stress may reinforce a psychosocial vicious cycle. Much of the mechanistic evidence comes from major depressive disorder, animal models, or in vitro studies; causality has not been established in pSS. The proposed multidimensional model is hypothetical and offers a framework for early screening and targeted intervention in pSS with depression.